11-94063665-C-T
Position:
Variant summary
Our verdict is Likely benign. Variant got -3 ACMG points: 2P and 5B. PM2BP4_ModerateBP6_ModerateBP7
The NM_001098672.2(HEPHL1):c.573C>T(p.Asp191=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000776 in 1,613,836 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.00058 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00080 ( 0 hom. )
Consequence
HEPHL1
NM_001098672.2 synonymous
NM_001098672.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.649
Genes affected
HEPHL1 (HGNC:30477): (hephaestin like 1) Enables ferroxidase activity. Involved in cellular iron ion homeostasis. Predicted to be integral component of membrane. Predicted to be active in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.32).
BP6
Variant 11-94063665-C-T is Benign according to our data. Variant chr11-94063665-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 2642291.Status of the report is criteria_provided_single_submitter, 1 stars.
BP7
Synonymous conserved (PhyloP=-0.649 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HEPHL1 | NM_001098672.2 | c.573C>T | p.Asp191= | synonymous_variant | 3/20 | ENST00000315765.10 | NP_001092142.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HEPHL1 | ENST00000315765.10 | c.573C>T | p.Asp191= | synonymous_variant | 3/20 | 5 | NM_001098672.2 | ENSP00000313699 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000579 AC: 88AN: 152108Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
88
AN:
152108
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000574 AC: 143AN: 248992Hom.: 0 AF XY: 0.000518 AC XY: 70AN XY: 135072
GnomAD3 exomes
AF:
AC:
143
AN:
248992
Hom.:
AF XY:
AC XY:
70
AN XY:
135072
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000796 AC: 1164AN: 1461610Hom.: 0 Cov.: 32 AF XY: 0.000761 AC XY: 553AN XY: 727086
GnomAD4 exome
AF:
AC:
1164
AN:
1461610
Hom.:
Cov.:
32
AF XY:
AC XY:
553
AN XY:
727086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000578 AC: 88AN: 152226Hom.: 0 Cov.: 32 AF XY: 0.000564 AC XY: 42AN XY: 74416
GnomAD4 genome
AF:
AC:
88
AN:
152226
Hom.:
Cov.:
32
AF XY:
AC XY:
42
AN XY:
74416
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Nov 01, 2022 | HEPHL1: BP4, BP7 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at